CSCO News Alert Cisco Systems (CSCO) 26.59 11/18/2014 20:47:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cisco Systems (CSCO) 26.59 $CSCO

Most active Nasdaq-traded stocks
AP - Tue Nov 18, 5:03PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
SPLS: 12.76 (-0.21), GILD: 103.71 (+3.27), FB: 74.34 (+0.10), DNDN: 0.13 (-0.02), MSFT: 48.74 (-0.72), INTC: 34.71 (+0.47), GRPN: 7.37 (-0.20), AAPL: 115.47 (+1.48), CSCO: 26.59 (+0.12)

Industry Leaders Unite to Form Streaming Video Alliance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 2:20PM CST
Select leading pay-TV operators, content providers and equipment vendors from around the world have combined forces to form the Streaming Video Alliance (SVA) ??? a new industry forum.
LVLT: 49.46 (+1.14), LBTYA: 46.72 (-0.11), ALU: 3.22 (+0.06), CHTR: 155.12 (-0.19), CMCSA: 54.42 (+0.27), CSCO: 26.59 (+0.12)

Cisco launches new conferencing hardware, unveils Project Squared
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 1:53PM CST

PLCM: 13.20 (+0.01), CSCO: 26.59 (+0.12)

Dividend Investors Should Focus On Stocks, Not The Market
Dividends4Life - Seeking Alpha - Tue Nov 18, 12:47PM CST
The election may be settled, but investors' fears are not. When Obama was first elected, the market plunged on worries of the looming Fiscal Cliff and European concerns. Budget negotiations began on Capitol Hill, optimism returned and the market...
KO: 43.53 (+0.61), T: 35.72 (-0.13), IBM: 161.89 (-2.27), XOM: 94.87 (-0.24), MSFT: 48.74 (-0.72), CSCO: 26.59 (+0.12)

Dow Jones (DJIA) Today: Cisco Systems (CSCO) Higher
at The Street - Tue Nov 18, 12:00PM CST
The Dow component leading the way higher looks to be Cisco Systems (Nasdaq:CSCO), which is sporting a 23-cent gain (+0.9%) bringing the stock to $26.70.
CSCO: 26.59 (+0.12)

Next Resistance Level for Cisco Systems (CSCO) is $26.89
Comtex SmarTrend(R) - Tue Nov 18, 11:39AM CST
Cisco Systems (NASDAQ:CSCO) has opened bullishly above the pivot of $26.34 today and has reached the first level of resistance at $26.67. Should the shares continue to rise, the resistance pivots of $26.89 and $27.44 will be of interest.
CSCO: 26.59 (+0.12)

AT&T And Cisco Redefine Cloud-Based Conferencing For Connected Devices
PR Newswire - Tue Nov 18, 9:00AM CST
Together, AT&T* and Cisco are helping to solve the next generation of collaboration needs by making conferencing more accessible for business users. AT&T will offer a new service** that lets customers quickly activate a conference with voice, video and content sharing using almost any connected device--including smartphones, tablets and desktop computers.
T: 35.72 (-0.13), CSCO: 26.59 (+0.12)

Today's Market: Japanese Economic Moves, Earnings And Corporate News
Matthew Smith - at Seeking Alpha - Tue Nov 18, 8:20AM CST

GPRO: 84.10 (+2.60), AMZN: 324.93 (+1.88), HD: 95.98 (-2.05), MSFT: 48.74 (-0.72), CSCO: 26.59 (+0.12)

Why Cisco Has A Fantastic Dividend!
Valuentum - at Seeking Alpha - Tue Nov 18, 8:19AM CST

CSCO: 26.59 (+0.12)

Stay Long Cisco
Seeking Profits - at Seeking Alpha - Tue Nov 18, 3:18AM CST

CSCO: 26.59 (+0.12)

Media Alert: Cisco and Sanford Bernstein to Host a Tech Talk on Cisco's Cloud Computing Strategy
Marketwired - Tue Nov 18, 2:36AM CST
Cisco (NASDAQ: CSCO) and Sanford Bernstein will host a Tech Talk to discuss Cisco's cloud computing strategy with Nick Earle, SVP, Cloud & Managed Services, who will give a brief presentation and address questions during the webcast/conference call. Interested parties can find more information on Cisco's Investor Relations website at http://investor.cisco.com.
CSCO: 26.59 (+0.12)

"Less Is More" as Cisco Completely Reimagines Flagship Three-Screen Video Conferencing Technology
Marketwired - Tue Nov 18, 2:35AM CST
For the past 24 months, Cisco (NASDAQ: CSCO) has been laser focused on delivering a completely revitalized, "no compromises" collaboration experience across our entire collaboration portfolio. From software to hardware, we've paid attention to details both big and small to deliver simple, affordable, and delightful collaboration experiences for every room, every desk and -- as announced today -- every pocket. Today at Collaboration Summit 2014, our marquee event for collaboration customers, partners, analysts and consultants, we're continuing that progress as we announce the complete overhaul of our flagship immersive video experience.
CSCO: 26.59 (+0.12)

Cisco Unveils Project Squared: a Next-Generation, Cloud-Based Collaboration App for Team Based Collaboration
Marketwired - Tue Nov 18, 2:35AM CST
Today at Collaboration Summit 2014, Cisco introduced Project Squared, a business collaboration app that combines chat, audio, video, multi-party meetings and content sharing in a single experience that supports the demanding collaboration needs of modern teams.
CSCO: 26.59 (+0.12)

Cisco Is A Strong Dividend Growth Candidate
Josh Arnold - at Seeking Alpha - Tue Nov 18, 1:33AM CST

CSCO: 26.59 (+0.12)

Apple, IBM, Cisco, Oracle Or Microsoft: Which Tech Giant Has The Most 'Effective' Buyback Program?
Brian Nichols - at Seeking Alpha - Mon Nov 17, 9:16PM CST

IBM: 161.89 (-2.27), MSFT: 48.74 (-0.72), AAPL: 115.47 (+1.48), ORCL: 41.26 (+0.10), CSCO: 26.59 (+0.12)

Cisco and Box Team Up to Advance Enterprise Collaboration
Business Wire - Mon Nov 17, 3:30PM CST
Cisco and Box today announced an alliance that includes product integrations to enhance content collaboration for Project Squared, Cisco's new business collaboration app that redefines how teams get work done. Together, Cisco and Box are making it easier and faster for teams to communicate and collaborate, accelerating productivity for global businesses. This integration also benefits security-conscious IT organizations that have standardized on Box as their secure enterprise content collaboration solution. Project Squared is built upon the Cisco Collaboration Cloud, a new, next-generation platform providing support for end-to-end content encryption.
CSCO: 26.59 (+0.12)

Technology Stock Roundup: Cisco Reports/Yahoo Buys BrightRoll - Analyst Blog
Sejuti Banerjea - Zacks Investment Research - Mon Nov 17, 9:54AM CST
Last week was highly eventful for the technology sector with the earnings announcement from Cisco (CSCO), new products from Apple (AAPL), Google (GOOGL), Amazon (AMZN), acquisitions by Yahoo (YHOO) and Microsoft (MSFT) and more.
AMZN: 324.93 (+1.88), FB: 74.34 (+0.10), GOOGL: 544.51 (-2.13), TWTR: 40.61 (+0.14), MSFT: 48.74 (-0.72), AAPL: 115.47 (+1.48), CSCO: 26.59 (+0.12)

Announcing the Most Admired Corporate Dealmakers for 2014
at The Street - Mon Nov 17, 9:50AM CST
The ten corporate dealmaking teams judged by our readers to be the best in the business this year.
REV: 32.96 (+0.21), DVN: 64.49 (+0.64), KR: 58.52 (+0.23), TMO: 120.50 (+2.07), VZ: 51.22 (-0.18), NRG: 31.74 (+0.06), HUN: 26.33 (+0.60), CSCO: 26.59 (+0.12), MS: 35.47 (-0.13)

Stock Market News for November 17, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 9:10AM CST
Benchmarks finished almost flat on Friday as Eurozone’s soft GDP data offset encouraging economic reports
DHI: 24.63 (+0.14), HAS: 56.12 (-0.25), BIIB: 305.56 (+3.14), VRTX: 111.04 (-0.58), HAL: 48.54 (-0.69), M: 61.45 (-0.16), WMT: 83.79 (+0.22), SLB: 95.28 (-0.35), COG: 33.27 (-0.26), GILD: 103.71 (+3.27), EOG: 97.67 (+1.32), ALXN: 192.37 (+5.59), MRO: 32.06 (+0.24), CSCO: 26.59 (+0.12), BHI: 63.55 (-1.68)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Schouw & Co.'s Share Buy-Back Strategy for 2025

Updated Category News Views 153

Overview of Schouw & Co.'s Share Buy-Back Program Schouw & Co. has launched an exciting share buy-back initiative, aiming to enhance shareholder value significantly. This program began on May 5, 2025, and is designed to repurchase shares totaling up to DKK 120 million. This investment runs until December 31, 2025, reflecting the company's commitment to its shareholders....

Continue Reading
Schneider National Plans to Reveal Q3 2024 Earnings Soon

Updated Category News Views 45

Schneider National to Report Third Quarter 2024 Earnings Schneider National, Inc. (NYSE: SNDR), a leader in transportation and logistics services, has announced that it will release its third quarter 2024 earnings report on a future date, ahead of the market opening. This announcement is significant as it highlights the company’s continued focus on financial...

Continue Reading
A Closer Look at BioAge Labs: Legal Challenges Ahead

Updated Category News Views 206

Understanding the Legal Landscape of BioAge Labs Investors in BioAge Labs, Inc. have faced new uncertainties as the clinical-stage biopharmaceutical company becomes entangled in legal challenges. As the firm moves forward in its mission to develop innovative therapies aimed at combating metabolic diseases, significant developments have emerged that every investor should...

Continue Reading
Celebrating the Fusion of Science and Cinema at Starmus 2025

Updated Category News Views 202

Fusion of Science and Cinema at Starmus Festival The Starmus Festival is a unique event that intertwines science and art, culminating in extraordinary dialogues and presentations. Recently, renowned director Christopher Nolan was awarded the prestigious Stephen Hawking Medal for Science Communication during this remarkable celebration. This accolade is not just an honor...

Continue Reading
Millicom Takes Steps to Enhance Transparency in Holdings

Updated Category News Views 82

Millicom Takes Steps to Enhance Transparency in Holdings Millicom International Cellular S.A., commonly recognized as Tigo, is making significant strides in open communication and compliance by submitting regulatory notifications regarding major shareholder holdings. This initiative reinforces their commitment to transparency and regulatory excellence in the ever-evolving...

Continue Reading